Forensic Phenotyping
The Future of Identification

                  
In the News  
 

 

PRESS RELEASES

Aug 16, 2013           AKESOgen and Identitas partner to provide a comprehensive Next Generation Forensic profiling solution
Jun 5, 2013              Identitas launches identify program for forensic phenotyping
Nov 13, 2012            Identitas publishes results of successful pilot program

NEW......

February 2015    Identitas featured in both the Financial Time (London)  and New York Times

                              articles on "New Forensic technologies"-

                             
                              http://app.ft.com/cms/s/012b2b9c-a742-11e4-8a71-00144feab7de.html?sectionid=home

                              http://mobile.nytimes.com/2015/02/24/science/building-face-and-a-case-on-dna.html?referrer=

 PRESS RELEASE May 2015

Identitas Licenses Novel Forensic Mixture Resolution Technology

Identitas USA, a next generation forensic technology company, is pleased to announce the completion of an exclusive worldwide license agreement with The Hebrew University of Jerusalem and Professor Ariel Darvasi, for a novel forensic sample mixture resolution technology.

 This unique approach can identify or exclude the presence of a given suspect in a crime scene DNA sample, Most importantly, this technology is applicable even when a mixture contains up to 10 different individuals, providing a novel solution to a problem that has long challenged investigators.

 Over the past two years, Identitas has validated its first in class ‘V1 Forensic chip’, which can define phenotypic, biogeographic ancestry and relationship data at very low levels of DNA, an important investigational tool in forensics, missing persons and security assessments.

 “Our newly acquired technology will enhance and complement our platform of unique molecular genetic forensic tools, and increase our opportunities to meaningfully advance forensic technology into the 21st century “, says Dr. Laurence Rubin, CEO of Identitas.

  We look forward to working with Professor Darvasi and his team to provide timely and effective solutions in complex and challenging case work, bringing our novel molecular technologies to routine application in forensic investigations.

PUBLICATIONS

First all-in-one diagnostic tool for DNA intelligence: genome-wide inference of biogeographic ancestry, appearance relatedness and sex with Identitas v1 Forensic Chip

11/13/12                         International Journal of Legal Medicine
http://link.springer.com/article/10.1007/s00414-012-0788-1

DNA goes to court

11/8/12                          Nature Biotechnology
http://www.nature.com/nbt/journal/v30/n11/full/nbt.2408.html


 
AKESOgen and Identitas partner to provide a comprehensive Next Generation Forensic profiling solution

New York, NY and Norcross, GA (August 16th 2013) -- Identitas Corp., a leader in forensic phenotyping and AKESOgen, the genomics and biorepository services company today announced a global commercial partnership to offer the forensic industry an innovative turn-key phenotypic screening solution that allows investigators to generate more comprehensive leads from DNA samples than had previously been possible. Financial terms were not disclosed.

“Our unique technology creates highly specific phenotypic predictions from DNA, combining inferences on biogeographic ancestry, extended relatedness/kinship, gender, Y and mitochondrial haplotype, and physical appearance such as hair and eye color. ISAS™ is able to generate investigative leads rapidly using only a single aliquot of DNA. We evaluate genome-wide single nucleotide polymorphisms (SNPs), to extract greater insight from DNA samples than has previously been possible” said Dr. Aruna Bansal, CIO of Identitas.

“We are excited to be working with Identitas to provide a comprehensive solution which we believe is unique in the forensic market and will have tremendous utility for enhanced phenotyping of individuals for a variety of applications including missing person identification as well as investigative lead generation, to complement standard panels such as CODIS.” commented Dr. Mark Bouzyk, CSO of AKESOgen.


The partnership will harness the combined strengths of both companies:  AKESOgen will provide an end-to-end genetic analysis packages powered by Identitas's proprietary ISASTM software analysis tool.  ISASTM employs a computationally powerful approach that interrogates single nucleotide polymorphisms (SNPs) to develop a profile that describes the physical appearance of an individual.  AKESOgen has entered into a license agreement with Identitas for access to the ISASTM software, enabling customers a seamless delivery of an enhanced phenotypic profile from receipt of DNA.

About AKESOgen, Inc.

AKESOgen is an integrated genomics and company providing biorepository services and high-throughput, biomarker profiling and genomics analysis utilizing different types of markers (e.g. DNA, mRNA, miRNA, methylation) for the R&D market in a CLIA environment. A private company based in Atlanta, GA, AKESOgen is a genomics contract research organization that services the government, academic, pharmaceutical, biotechnology, clinical testing and agricultural sectors. AKESOgen provides expertise in biobanking, assay development and all ancillary services in a purpose-built facility. For more information, visit www.akesogen.com.

About Identitas Corp.

Identitas Corp. is a forensic genomics company developing better ways to extract information from genetic evidence. Their lead software product, ISAS™, is an all-in-one solution that generates highly detailed profiles from a single DNA sample. ISAS™ provides simple, intuitive reports of high resolution data that describe familial relatedness, bio-geographic ancestry/location of origin, and visual phenotyping. For more information, visit www.identitascorp.com.

 

 

 
Identitas launches iDENTIFY program for forensic phenotyping

NEW YORK, NY (June 5, 2013) -- Identitas today announced the launch of iDENTIFY, a limited time offer for forensics practitioners wishing to try out the company’s ISAS™ technology at low cost and low risk. The iDENTIFY program offers special promotional pricing and other incentives for investigators who wish to pursue proof of concept and/or collaborative validation studies using the company’s proprietary visual phenotyping software.

ISAS™ uses a custom comprehensive panel of single nucleotide polymorphisms (SNPs) to develop a highly detailed visual profile from a single DNA sample. The profile includes biogeographic ancestry, extended familial relationships, and physical features (such as eye color, hair color, etc.) to identify investigative leads of deeper resolution with greater confidence.

As part of the iDENTIFY program, investigators will have the opportunity to evaluate ISAS™ in two ways: as a turn-key solution (where clients provide DNA and receive the results of analysis from Identitas) or using the ISAS™ App (where DNA and data are maintained exclusively by the client and a desktop application is installed directly at their site).

“We are pleased to offer the iDENTIFY program, which provides forensics practitioners with a means to go beyond the constraints of traditional STR-based DNA analysis approaches, said Laurence Rubin, CEO. “In many cases, the value locked in DNA samples cannot be realized when there is no hit in existing criminal databases. The iDENTIFY program creates the opportunity for investigators to go beyond these constraints and generate much richer investigative leads for these stalled cases.”

For further information about iDENTIFY and to see if your project qualifies for the promotional pricing, please visit the Identitas website at www.identitascorp.com.

About Identitas

Identitas Corp. is a forensic genomics company developing better ways to extract information from genetic evidence. Their lead software product, ISAS™, is an all-in-one solution that generates highly detailed profiles from a single DNA sample. ISAS™ provides simple, intuitive reports of high resolution data that describe familial relatedness, bio-geographic ancestry/location of origin, and visual phenotyping. For more information, visit www.identitascorp.com.


 
Identitas publishes results of successful pilot program

NEW YORK, NY (November 13, 2012) -- Identitas Corp. today announced the publication of the successful results of a collaborative genotype study using the Identitas v1 Forensic Chip and the company’s proprietary ISAS™ software. This innovative technology interrogates 201,173 genome-wide autosomal, X-chromosomal, Y-chromosomal, and mitochondrial single nucleotide polymorphisms (SNPs) for inference of biogeographic ancestry, appearance, relatedness, and gender. Published in the International Journal of Legal Medicine, this study involved an international, industry-academic collaboration, between Identitas, the International Visible Trait Genetic (VisiGen) Consortium, and several governmental forensic labs in the USA and Canada.

These results confirmed that this novel technology can generate both investigative leads, and likely exclusions, in situations where a forensic DNA sample returns 'no match'. Despite the enormous geographic diversity of the DNA samples involved, predictions of biogeographic ancestry were 93% correct in the 95% of samples that passed QC. The Y-chromosome and mitochondrial haplogroups added clarity to the genome-wide inferences, especially when the sample in question belonged to an individual of mixed race origin. Importantly, accurate predictions were reliably determined from realistic amounts of DNA: as little as 1.75ng.

The new method displayed a marked improvement in performance over existing kinship analyses based upon STRs. The use of genome-wide SNPs meant that up to third-degree familial relationships are correctly identified: ranging from father/son relationships to first-cousin and great-uncle/ great-nephew relationships. The data generated offers the opportunity of quick resolution in missing persons cases, and of time-saving and unprecedented certainty in questions of homeland security.

"This study demonstrates the exceptional resolution and accuracy of the Identitas v1 Forensic Chip and ISAS™ analysis software, in predicting bio-geographic ancestry, appearance, kinship, and gender from a forensic DNA sample,” said Dr. Aruna Bansal, Chief Information Officer of Identitas. “Particularly in investigations in which a forensic DNA sample returns no match in criminal databases, this technology offers new insights and novel investigative leads.  Because this comprehensive all-in-one tool requires only one aliquot of DNA, it preserves valuable genetic evidence and provides exceptional value for investigators.”

For further information about the study, visit
www.identitascorp.com or “First all-in-one diagnostic tool for DNA intelligence: genome-wide inference of biogeographic ancestry, appearance relatedness and sex with Identitas v1 Forensic Chip” http://link.springer.com/article/10.1007/s00414-012-0788-1/fulltext.html.

About Identitas

Identitas Corp. is a forensic genomics company developing better ways to extract information from genetic evidence. Their lead software product, ISAS™, is an all-in-one solution that generates highly detailed profiles from a single DNA sample. ISAS™ provides simple, intuitive reports of high resolution data that describe familial relatedness, bio-geographic ancestry/location of origin, and visual phenotyping. For more information, visit
www.identitascorp.com.


http://mobile.nytimes.com/2015/02/24/science/building-face-and-a-case-on-dna.html?referrer=

Website Builder